UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029028
Receipt number R000033204
Scientific Title Improvement of brain function due to long-term chocolate intake.
Date of disclosure of the study information 2017/09/06
Last modified on 2019/12/09 10:44:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Improvement of brain function due to long-term chocolate intake.

Acronym

Chocolate intake and brain function

Scientific Title

Improvement of brain function due to long-term chocolate intake.

Scientific Title:Acronym

Chocolate intake and brain function

Region

Japan


Condition

Condition

Adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effect of long-term administration of chocolate on human cognitive functions.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Stroop color word test

Key secondary outcomes

1) Cerebral blood flow
2) Blood composition


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Oral intake of dark chocolate (4 weeks)
24 g/day (135 kcal/day)

Interventions/Control_2

Oral intake of white chocolate (4 weeks)
24.5 g/day (145 kcal/day)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

35 years-old >=

Gender

Male and Female

Key inclusion criteria

1)Those who are more than 20 years old.
2)Those who agreed to participate in research.
3)Those who have no health problems.

Key exclusion criteria

1)Those who have a smoking habit.
2)Those who intake caffeine more than 400 mg per day.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Eri Sumiyoshi

Organization

Shimane University

Division name

Faculty of Medicine

Zip code


Address

89-1 Enya cho Izumo city 693-8501

TEL

0853-20-2114

Email

erisumi@med.shimane-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoko Tanabe

Organization

Shimane University

Division name

Faculty of Medicine

Zip code


Address

89-1 Enya cho Izumo city 693-8501

TEL

0853-20-2113

Homepage URL


Email

tanabey@med.shimane-u.ac.jp


Sponsor or person

Institute

Shimane University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 09 Month 06 Day


Related information

URL releasing protocol

https://www.ncbi.nlm.nih.gov/pubmed/31744119

Publication of results

Published


Result

URL related to results and publications

https://www.ncbi.nlm.nih.gov/pubmed/31744119

Number of participants that the trial has enrolled

20

Results

DC intake significantly increased the score of the SCWT and the D-CAT at Post compared with those at Pre. At 3 weeks after the end of the intervention (FU), the score of these tests remained at a higher level than those at Pre. However, WC intake group did not change throughout the intervention period. For the DC group, the level of Nerve Growth Factor (NGF) was increased at Post and returned to baseline at FU. However, WC intake group did not change throughout the intervention period.

Results date posted

2019 Year 12 Month 09 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2019 Year 11 Month 14 Day

Baseline Characteristics

Healthy young subjects (14 men and 6 women, ages 20-31 years old) were recruited from Japanese undergraduate students.
Subjects were screened for the following inclusion criteria: nonsmokers, not medicated, and without obvious clinical symptoms and problems, such as hypertension, diabetes, and gastrointestinal disorders.

Participant flow

Each subject provided written and informed consent after all procedures and potential risks were explained.
Subjects took chocolate (dark or white) daily for 30 days (Chocolate intake intervention). The subjects' physical characteristics, cognitive function test, and PFCBF were recorded pre (Pre) and post intervention (Post) and at a follow up (FU) visit, 3 weeks after the end of the intervention. Blood was sampled before chocolate intake (Baseline), during the chocolate intake intervention (1, 2, 3 and 4 weeks) and FU.

Adverse events

Not applicable.

Outcome measures

The primary outcomes were improvement of cognitive function by dark chocolate ingestion,estimated using the paper version of the SCWT (modified SCWT) and the D-CAT. Secondary outcome was elevated neurotrophin concentration in the plasma.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 08 Month 20 Day

Date of IRB

2017 Year 01 Month 30 Day

Anticipated trial start date

2017 Year 09 Month 07 Day

Last follow-up date

2017 Year 12 Month 19 Day

Date of closure to data entry


Date trial data considered complete

2019 Year 04 Month 01 Day

Date analysis concluded

2019 Year 04 Month 30 Day


Other

Other related information



Management information

Registered date

2017 Year 09 Month 06 Day

Last modified on

2019 Year 12 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033204


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name